Taisho Pharmaceutical R&D
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Taisho Pharmaceutical R&D sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,751 sponsors by registered trial count).
Taisho Pharmaceutical R&D: 8 sponsored US clinical trials, none currently recruiting.
Taisho Pharmaceutical R&D sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 1 trials.
Upper-quartile sponsor footprint
Taisho Pharmaceutical R&D sits in the upper quartile of the sponsor corpus (#1,604 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants
NCT04464239
First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants
NCT03919409
A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder
NCT03093025
Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects
NCT03141658
Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers
NCT03742791
Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers
NCT03746067
Exploratory Study Using Positron Emission Tomography With TS-121 and [11C]TASP0410699 in Healthy Adult Male Subjects
NCT02448212
Study of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)
NCT00914186
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 2 |
Therapeutic Areas
How the Taisho Pharmaceutical R&D early-phase archive is shaped
8 indexed studies, none listed as recruiting (0% open); 7 completed (88%).
Phase mix: 0 late (III/IV) vs 8 early (I/II) (early-phase heavy).
Top condition: Healthy (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.